Adial Pharmaceuticals Inc. (ADIL)
Market Closed
10 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
6. 00
+0.07
+1.0961%
Pre Market
$
+1.21 +20.2669% 7. 21
6.38M Market Cap
- P/E Ratio
- Div Yield
17,237 Volume
-4.8 Eps
$ 5.93
Previous Close Investors:
Want to track ADIL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adial Pharmaceuticals Inc. (ADIL) Statistics
Valuation metrics
Market Cap 6.38M
Enterprise value -21.88M
Trailing P/E (ttm) -0.43
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 210.94
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 50.1K
Average volume (90 days) 144.36K
Price summary
52-Week low 1.31
52-Week high 10.75
Beta -
50-Day moving average 3.67
200-Day moving average 2.11
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 6 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.99%
Return on equity -16.93%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -12.51
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.21
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 5.63%
Book value per share (mrq) 0.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
